Search Results - "Falzea, Antonia Consuelo"

Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade by Nardone, Valerio, Giannicola, Rocco, Bianco, Giovanna, Giannarelli, Diana, Tini, Paolo, Pastina, Pierpaolo, Falzea, Antonia Consuelo, Macheda, Sebastiano, Caraglia, Michele, Luce, Amalia, Zappavigna, Silvia, Mutti, Luciano, Pirtoli, Luigi, Giordano, Antonio, Correale, Pierpaolo

“…Peripheral-immune-checkpoint blockade (P-ICB) with mAbs to PD-1 (nivolumab and pembrolizumab) or PD-L1 (atezolizumab, durvalumab, avelumab) alone or…”
Get full text

Myositis/Myasthenia after Pembrolizumab in a Bladder Cancer Patient with an Autoimmunity-Associated HLA: Immune–Biological Evaluation and Case Report by Botta, Cirino, Agostino, Rita Maria, Dattola, Vincenzo, Cianci, Vittoria, Calandruccio, Natale Daniele, Bianco, Giovanna, Mafodda, Antonino, Maisano, Roberto, Iuliano, Eleonora, Orizzonte, Giovanna, Mazzacuva, Domenico, Falzea, Antonia Consuelo, Saladino, Rita Emilena, Giannicola, Rocco, Restifo, Giorgio, Aguglia, Umberto, Caraglia, Michele, Correale, Pierpaolo

“…Pembrolizumab (mAb to PD-1) has been recently approved for the therapy of pretreated urothelial cancer. Despite the efficacy, it is often accompanied by…”
Get full text

Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade by Correale, Pierpaolo, Saladino, Rita Emilena, Giannarelli, Diana, Giannicola, Rocco, Agostino, Rita, Staropoli, Nicoletta, Strangio, Alessandra, Del Giudice, Teresa, Nardone, Valerio, Altomonte, Maria, Pastina, Pierpaolo, Tini, Paolo, Falzea, Antonia Consuelo, Imbesi, Natale, Arcati, Valentina, Romeo, Giuseppa, Caracciolo, Daniele, Luce, Amalia, Caraglia, Michele, Giordano, Antonio, Pirtoli, Luigi, Necas, Alois, Amler, Evzen, Barbieri, Vito, Tassone, Pierfrancesco, Tagliaferri, Pierosandro

“…BackgroundNivolumab is a human monoclonal antibody against programmed cell death receptor-1 (PD-1) able to rescue quiescent tumor infiltrating cytotoxic T…”
Get full text

HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis by Correale, Pierpaolo, Saladino, Rita Emilena, Giannarelli, Diana, Sergi, Andrea, Mazzei, Maria Antonietta, Bianco, Giovanna, Giannicola, Rocco, Iuliano, Eleonora, Forte, Iris Maria, Calandruccio, Natale Daniele, Falzea, Antonia Consuelo, Strangio, Alessandra, Nardone, Valerio, Pastina, Pierpaolo, Tini, Paolo, Luce, Amalia, Caraglia, Michele, Caracciolo, Daniele, Mutti, Luciano, Tassone, Pierfrancesco, Pirtoli, Luigi, Giordano, Antonio, Tagliaferri, Pierosandro

“…Tumor-infiltrating T cell rescue by programmed cell death receptor-1 (PD-1)/PD-1 ligand-1 (PD-L1) immune checkpoint blockade is a recommended treatment for…”
Get full text

Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis by Nardone, Valerio, Giannicola, Rocco, Giannarelli, Diana, Saladino, Rita Emilena, Azzarello, Domenico, Romeo, Caterina, Bianco, Giovanna, Rizzo, Maria Rosaria, Di Meo, Irene, Nesci, Antonio, Pastina, Pierpaolo, Falzea, Antonia Consuelo, Caracciolo, Daniele, Reginelli, Alfonso, Caraglia, Michele, Luce, Amalia, Mutti, Luciano, Giordano, Antonio, Cappabianca, Salvatore, Pirtoli, Luigi, Barbieri, Vito, Tassone, Pierfrancesco, Tagliaferri, Pierosandro, Correale, Pierpaolo

“…An immune checkpoint blockade with mAbs to PD-1 and PD-L1 is an expanding therapeutic option for mNSCLC patients. This treatment strategy is based on the use…”
Get full text

Evaluation of long term survival in pretreated metastatic colorectal cancer patients undergoing GOLFIG chemoimmunotherapy regimen by Correale, Pierpaolo, Giannicola, Rocco, Staropoli, NIcoletta, Ciliberto, Domenico, Azzarello, Domenico, Tripepi, Giovanni, Agostino, Rita Maria, Strangio, Alessandra, Altomonte, Maria, Nesci, Antonio, Francini, Guido, Pastina, Pierpaolo, Tassone, Pierfrancesco, Pirtoli, Luigi, Caporlingua, Nadia, Falzea, Antonia Consuelo, Tagliaferri, Pierosandro

“…Abstract only e15057 Background: In the last few years, there has been a renewed interest on the potential use of immunotherapy alone or combined to…”
Get full text

Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab by Giannicola, Rocco, D'Arrigo, Graziella, Botta, Cirino, Agostino, Rita, Del Medico, Pietro, Falzea, Antonia Consuelo, Barbieri, Vito, Staropoli, Nicoletta, Del Giudice, Teresa, Pastina, Pierpaolo, Nardone, Valerio, Monoriti, Marika, Calabrese, Graziella, Tripepi, Giovanni, Pirtoli, Luigi, Tassone, Pierfrancesco, Tagliaferri, Pierosandro, Correale, Pierpaolo

“…Immune-checkpoint blockade by Nivolumab, a human monoclonal antibody to programmed cell death receptor-1, is an emerging treatment for metastatic non-small…”
Get full text

Correlation of survival of NSCLC patients given nivolumab with treatment related-eosinophilia, autoimmunity and previous bevacizumab containing regimens by Giannicola, Rocco, D'arrigo, Graziella, Pastina, Pierpaolo, Caraglia, Michele, Nardone, Valerio, Botta, Cirino, Barbieri, Vito, Tassone, Pierfrancesco, Misso, Gabriella, Zappavigna, Silvia, Monoriti, Marika, Porto, Gaetana, Tripepi, Giovanni, Tagliaferri, Pierosandro, Pirtoli, Luigi, Falzea, Antonia Consuelo, Correale, Pierpaolo

“…Abstract only…”
Get full text